Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: a meta-analysis.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 21964956)

Published in Liver Transpl on January 01, 2012

Authors

Wenhua Liang1, Dongping Wang, Xiaoting Ling, Andrew Allen Kao, Yuan Kong, Yushu Shang, Zhiyong Guo, Xiaoshun He

Author Affiliations

1: Organ Transplant Center, First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan Er Road, Guangzhou, China.

Articles citing this

Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant (2012) 1.88

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59

2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Gut Liver (2015) 1.23

Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends. J Hepatol (2013) 1.22

2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol (2015) 1.14

The mTOR pathway in hepatic malignancies. Hepatology (2013) 1.02

Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. Rev Diabet Stud (2012) 0.99

Hepatocellular carcinoma: A comprehensive review. World J Hepatol (2015) 0.98

Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition. Liver Cancer (2012) 0.98

Management of hepatocellular carcinoma. J Cancer Res Clin Oncol (2014) 0.96

Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma. Hepatol Res (2012) 0.96

Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant (2014) 0.94

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates. Ann Oncol (2013) 0.91

Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World J Gastroenterol (2015) 0.87

Long-term medical management of the liver transplant recipient: what the primary care physician needs to know. Mayo Clin Proc (2012) 0.86

Current status of immunosuppression in liver transplantation. J Clin Exp Hepatol (2013) 0.86

Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis. Dtsch Arztebl Int (2013) 0.83

Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol (2015) 0.82

Liver Transplantation for HCC: A Review. Indian J Surg (2011) 0.82

Management of recurrent hepatocellular carcinoma after liver transplant. World J Hepatol (2015) 0.81

Post-transplantation malignancies: here today, gone tomorrow? Nat Rev Clin Oncol (2015) 0.81

Management of hepatocellular carcinoma: an overview of major findings from meta-analyses. Oncotarget (2016) 0.81

Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun. Surg Today (2016) 0.81

Progress in the treatment of pulmonary metastases after liver transplantation for hepatocellular carcinoma. World J Hepatol (2015) 0.80

Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience. World J Hepatol (2015) 0.79

Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol (2017) 0.78

Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials. Oncotarget (2015) 0.77

Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma. Liver Cancer (2015) 0.77

Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77

Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis. World J Hepatol (2015) 0.76

Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence. Transl Gastroenterol Hepatol (2016) 0.75

Hepatobiliary quiz-7 (2013). J Clin Exp Hepatol (2013) 0.75

Differential Sensitivities of Fast- and Slow-cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic Acid. Mol Med (2015) 0.75

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review. World J Gastroenterol (2016) 0.75

Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome. ISRN Hepatol (2014) 0.75

Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection? Transl Gastroenterol Hepatol (2017) 0.75

Articles by these authors

Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model. J Med Chem (2005) 1.80

Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics (2008) 1.78

Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell (2009) 1.77

Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer. Mol Cancer Ther (2008) 1.59

The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells. J Biol Chem (2007) 1.55

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy. Oncotarget (2014) 1.51

Living donor vs. deceased donor liver transplantation for patients with hepatitis C virus-related diseases. J Hepatol (2012) 1.44

Prediction of accrual closure date in multi-center clinical trials with discrete-time Poisson process models. Pharm Stat (2012) 1.43

Tetracarboxylate-based Co(II), Ni(II) and Cu(II) three-dimensional coordination polymers: syntheses, structures and magnetic properties. Dalton Trans (2010) 1.39

The association of health insurance and continuous primary care in the medical home on vaccination coverage for 19- to 35-month-old children. Pediatrics (2007) 1.33

HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology (2004) 1.28

Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole. Cancer Res (2006) 1.22

Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells. J Biol Chem (2011) 1.21

Tyrosine kinase Etk/BMX is up-regulated in human prostate cancer and its overexpression induces prostate intraepithelial neoplasia in mouse. Cancer Res (2006) 1.20

Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors. J Biol Chem (2013) 1.18

Genome sequence analyses of Pseudomonas savastanoi pv. glycinea and subtractive hybridization-based comparative genomics with nine pseudomonads. PLoS One (2011) 1.18

Advances in distinguishing natural from induced Foxp3(+) regulatory T cells. Int J Clin Exp Pathol (2013) 1.13

1H and 13C NMR assignments for two anthraquinones and two xanthones from the mangrove fungus (ZSUH-36). Magn Reson Chem (2007) 1.12

Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells. Oncogene (2004) 1.12

Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells. Cancer Res (2010) 1.11

"Default" generation of neonatal regulatory T cells. J Immunol (2010) 1.10

Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2. Mol Endocrinol (2006) 1.06

Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation. Arthritis Rheum (2013) 1.05

Differential lysine acetylation profiles of Erwinia amylovora strains revealed by proteomics. J Proteomics (2012) 1.03

Systems level analysis of two-component signal transduction systems in Erwinia amylovora: role in virulence, regulation of amylovoran biosynthesis and swarming motility. BMC Genomics (2009) 1.01

The anti-ulcer activities of bisabolangelone from Angelica polymorpha. J Ethnopharmacol (2009) 1.01

A luminescent mixed-lanthanide metal-organic framework thermometer. J Am Chem Soc (2012) 1.01

Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver Transpl (2012) 1.00

Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration. PLoS One (2012) 1.00

Construction and analysis of pathogenicity island deletion mutants of Erwinia amylovora. Can J Microbiol (2009) 0.98

The development and function of follicular helper T cells in immune responses. Cell Mol Immunol (2012) 0.98

Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis. Transplantation (2012) 0.98

Testosterone signaling in T cells and macrophages. Steroids (2002) 0.94

CDC25A functions as a novel Ar corepressor in prostate cancer cells. J Mol Biol (2008) 0.94

Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage. J Biol Chem (2004) 0.93

Characterization of the middle hepatic artery and its relevance to living donor liver transplantation. Liver Transpl (2010) 0.93

Diazoxide prevents diabetes through inhibiting pancreatic beta-cells from apoptosis via Bcl-2/Bax rate and p38-beta mitogen-activated protein kinase. Endocrinology (2006) 0.91

Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies. Transplantation (2014) 0.90

Expression profiles of differentially regulated genes during the early stages of apple flower infection with Erwinia amylovora. J Exp Bot (2011) 0.89

Synthesis of a new Ni-phenanthroline complex and its application as an electrochemical probe for detection of nucleic acid. Biosens Bioelectron (2011) 0.89

IL-2-deprivation and TGF-beta are two non-redundant suppressor mechanisms of CD4+CD25+ regulatory T cell which jointly restrain CD4+CD25- cell activation. Immunol Lett (2010) 0.89

Tyrosine kinase ETK/BMX is up-regulated in bladder cancer and predicts poor prognosis in patients with cystectomy. PLoS One (2011) 0.89

Inhibition of Staphylococcus aureus pathogenesis in vitro and in vivo by RAP-binding peptides. Peptides (2003) 0.89

In-hospital cerebrovascular complications following orthotopic liver transplantation: a retrospective study. BMC Neurol (2008) 0.88

Parents questioning immunization: evaluation of an intervention. Am J Health Behav (2008) 0.88

Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients. Surg Today (2009) 0.87

Machine perfusion versus cold storage of kidneys derived from donation after cardiac death: a meta-analysis. PLoS One (2013) 0.84

Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: a meta-analysis. Int J Cancer (2014) 0.84

Source document verification in the Mucopolysaccharidosis Type I Registry. Pharmacoepidemiol Drug Saf (2011) 0.84

Induced CD4+ forkhead box protein-positive T cells inhibit mast cell function and established contact hypersensitivity through TGF-β1. J Allergy Clin Immunol (2012) 0.84

Managed care organizations' performance in delivery of childhood immunizations (HEDIS, 1999-2002). Am J Manag Care (2007) 0.83

Donor-derived bone marrow transfusion produces mixed chimerism and promotes a Th2 shift in Th1/Th2 balance in rat heterotopic small bowel transplantation. Dig Liver Dis (2012) 0.83

Recombinant adiponectin ameliorates liver ischemia reperfusion injury via activating the AMPK/eNOS pathway. PLoS One (2013) 0.83

Calcineurin-inhibitor minimization in liver transplant patients with calcineurin-inhibitor-related renal dysfunction: a meta-analysis. PLoS One (2011) 0.83

Synthesis of novel C17 steroidal carbamates. Studies on CYP17 action, androgen receptor binding and function, and prostate cancer cell growth. Steroids (2008) 0.82

Liver transplantation at the Sun Yat-Sen University of Medical Sciences in China. Chin Med J (Engl) (2002) 0.82

Ultrafast double potential step chronoamperometry with the time window down to submicrosecond. Anal Sci (2004) 0.81

Diagnosis and treatment of acute appendicitis after orthotopic liver transplant in adults. Exp Clin Transplant (2011) 0.81

Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis. Transplantation (2012) 0.81

Hepatic artery thrombosis after orthotopic liver transplant: a review of the same institute 5 years later. Exp Clin Transplant (2011) 0.81

IL-7, but not thymic stromal lymphopoietin (TSLP), during priming enhances the generation of memory CD4+ T cells. Immunol Lett (2010) 0.80

Sirolimus conversion in liver transplant recipients with calcineurin inhibitor-induced complications: efficacy and safety. Exp Clin Transplant (2012) 0.79

Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation. Am J Hematol (2015) 0.79

Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus. Exp Clin Transplant (2012) 0.79

Ethnobotany of dye plants in Dong communities of China. J Ethnobiol Ethnomed (2014) 0.79